For instance, by utilizing next-generation sequencing (NGS), Yeh et al. showed that SDC1 expression was negative with OS, suggesting that SDC1 might serve as a valid independent prognostic biomarker for breast ductal carcinoma [29]. The gene discussed is SDC1; the disease is breast ductal adenocarcinoma.